American Society of Clinical Oncology (ASCO)
Alexandria, VA USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Panel Recommends Primary Palliative Care Services for Medical Oncology Practices

A new guidance statement from the American Society of Clinical Oncology and the American Academy of Hospice and Palliative Medicine is being presented for the first time at the 2015 Palliative Care in Oncology Symposium in Boston.
5-Oct-2015 5:05 PM EDT Add to Favorites

Innovative Collaboration Among Radiation Oncologists and Palliative Care Specialists Improves Care for Patients With Advanced Cancers

An innovative service model that partners radiation oncology with palliative care leads to better results for patients, according to a new analysis. The model of care, established at Mount Sinai Medical Center in New York, is one of only a handful...
5-Oct-2015 5:05 PM EDT Add to Favorites

New Evidence for a Strategy to Identify Patients Nearing the End of Life

ALEXANDRIA, Va. – A new study provides compelling evidence that a simple tool can help predict which patients with cancer may be in their final year of life. The tool, known as the Surprise Question, was found to predict the risk of cancer death...
5-Oct-2015 5:00 PM EDT Add to Favorites

Early Evidence of Increase in Higher-Risk Prostate Cancers From 2011-2013

An analysis of data on roughly 87,500 men treated for prostate cancer since 2005 finds a notable increase in higher-risk cases of the disease between 2011 and 2013. The study will be presented at the upcoming 2015 Genitourinary Cancers Symposium in...
23-Feb-2015 6:30 PM EST Add to Favorites

Adjuvant Sorafenib and Sunitinib Do Not Improve Outcomes in Locally Advanced Kidney Cancer

Findings from a federally funded study suggest that patients with locally advanced kidney cancer should not be treated with either adjuvant (post-surgery) sorafenib or sunitinib. The average period to disease recurrence was similar between those who...
23-Feb-2015 6:05 PM EST Add to Favorites

Active Surveillance of Intermediate-Risk Prostate Cancer Associated With Decreased Survival

An analysis of data on 945 patients with prostate cancer that is managed with active surveillance shows differences in outcomes depending on whether the patient was low or intermediate risk at diagnosis. Compared to patients with low-risk disease,...
23-Feb-2015 6:00 PM EST Add to Favorites

Men Who Have Had Testicular Cancer Are More Likely to Develop Prostate Cancer, Although Overall Risk of Developing Aggressive Disease is Low

A case-control study of close to 180,000 men suggests that the incidence of prostate cancer is higher among men with a history of testicular cancer (12.6 percent) than among those without a history of testicular cancer (2.8 percent). Men who have...
23-Feb-2015 6:00 PM EST Add to Favorites

Androgen Receptor Abnormality May Not Be Associated With Primary Resistance to Taxane Chemotherapy

ALEXANDRIA, Va. – Findings from a small prospective study suggest that androgen receptor V7 (or AR-V7) status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant prostate cancer (mCRPC)....
23-Feb-2015 6:00 PM EST Add to Favorites

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos